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Abstract
Cardiac resynchronisation therapy is an established therapy for patients with advanced heart failure, decreased left 
ventricular ejection fraction, a wide QRS syndrome, and the presence of left ventricular dyssynchrony despite optimal 
pharmacotherapy. The key feature for applied treatment is proper qualification and the optimal placing of left ventricular 
electrode implantation. The major issues that limit resynchronisation therapy are high left ventricle pacing threshold and 
phrenic nerve stimulation (PNS). PNS occurs in 30% of patients at implantation. In this paper, we present alternative 
methods of avoiding PNS based on the latest clinical trials and our own experience.
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Introduction
Heart failure (HF) is one of the most common cardiovas-
cular diseases in Europe and the United States. Despite 
significant advances in the diagnosis and treatment of the 
diseases that cause it, such as coronary artery disease 
and hypertension, the number of patients with HF is on 
the rise.
In Poland, its symptoms are estimated to occur in 
700,000 to 1,000,000 patients, which is 2.5% of the ge-
neral population: 2% of those aged 40–59 and more than 
10% of people aged over 70 [1]. Despite the introduction 
of new pharmacological treatments, it is estimated that 
more than one million patients with HR require hospita-
lisation, of whom about 20% will need re-admission to 
hospital within one month of discharge, and up to 50% 
within six months. These patients are burdened with nearly 
12% 30-day mortality, and up to 33% during 12 months 
follow-up. Sudden cardiac death (SCD) among patients 
with HR occurs 6–9 times more often than in the general 
population. Cardiac resynchronisation therapy (CRT) has an 
important place as a valuable supplement in the treatment 
of these patients in addition to optimal pharmacotherapy.
In 1994, researchers from two independent teams 
(Cazeau et al. from France and Bakker et al. from the 
Netherlands) described the beneficial effect of simultaneo-
us biventricular stimulation in patients with left ventricular 
systolic dysfunction and prolonged QRS syndromes. Since 
then, there has been an unusually rapid development of 
cardiac electrotherapy as a treatment for HR in patients 
without indications for pacemaker implantation due to 
conduction abnormalities.
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Resynchronisation therapy
According to the latest guidelines of the European Society 
of Cardiology (ESC), this form of therapy is indicated for 
patients with symptomatic HR in New York Heart Asso-
ciation (NYHA) functional classes II–IV despite optimal 
pharmacotherapy, with significant impairment of left 
ventricular systolic function [ejection fraction (EF) < 35%] 
and prolonged QRS syndrome (> 130 ms) against a back-
ground of intraventricular conduction abnormalities, while 
maintaining sinus rhythm [2]. In this group of patients, the 
beneficial effect of CRT on prognosis, improvement of qual-
ity of life, as well as reduction of HR symptoms expressed 
as a reduction in the frequency of hospitalisation due to 
HR, have been proved based on many randomised clinical 
trials [e.g. COMPANION (Comparison of Medical Therapy, 
Pacing, and Defibrillation in Heart Failure), CARE-HF (Car-
diac Resynchronization-Heart Failure)] [3, 4]. Disturbances 
in electrical activation in the heart with impaired systolic 
function may cause dyssynchronisation:
 — atrioventricular — ineffective filling of the left ventricle 
and its delayed contraction in relation to the atrial 
contraction;
 — interventricular — no simultaneous contraction of the 
right and left ventricles;
 — intraventricular — desynchronous contraction of indivi-
dual segments of the left ventricle muscle.
CRT works by restoring synchronous two-chamber 
stimulation through electrodes introduced into the heart 
through the venous system. The right ventricular pacing 
electrode with cardioversion/defibrillation function (CRT-D) 
is placed in the right ventricle apex or ventricular septum, 
depending on the sensing/pacing parameters. However, 
the key role in response to CRT is the introduction of the 
left ventricular electrode through the coronary sinus to the 
place with the greatest delay in electrical activation of the 
left ventricular muscle. This is usually the epicardial vein 
located on the posterior or lateral wall. This site can be loca-
ted non-invasively by modern methods of echocardiography 
(Doppler tissue technique or speckle tracking imaging) or 
by nuclear magnetic resonance [5, 6]. The condition for 
successful stimulation of the left ventricular electrode in 
this area is the absence of a scar to ensure propagation 
of proper simulation parameters and pulse. Despite this, 
the successful implantation of the left ventricular electrode 
is additionally determined by several aspects such as [7]:
 — operator experience;
 — availability of different sets for coronary sinus intuba-
tion (various shapes and curves);
 — availability of catheters for selective intubation of 
heart veins;
 — possibility of widening the vein with angioplasty;
 — ability to stabilise the electrode in the vein with a stent.
If the left ventricular electrode cannot be implanted 
through the coronary sinus, as an alternative an epicardial 
suture electrode may be used during cardiac surgery by la-
teral microthoracotomy or thoracoscopy [7]. This procedure 
is very rare in Poland. It is mainly caused by the occurrence 
of serious thromboembolic complications and a high risk 
of peri-electrodal bacterial endocarditis.
The percentage of resynchronisation stimulation is very 
important from a clinical point of view. Based on many 
multicentre studies, it has been proven that the higher the 
percentage of resynchronisation stimulation, the greater 
the benefit of the therapy. According to current recommen-
dations, it is believed that the percentage of two-chamber 
stimulation should be as close as possible to 100%.
However, despite a large number of implantable re-
synchronisation systems and progressive experience, 
20–30% of patients still do not respond to the therapy 
(non-responders). The success of the therapy depends on 
the proper selection of patients (clinical symptoms, low 
ejection fraction, duration of QRS syndrome with left bundle 
branch block (LBBB) morphology (class I recommendations 
according to ESC) and the features of dyssynchronisation 
of left ventricular contraction, but also on the presence of 
viable left ventricular myocardium with the latest electri-
cal activation. In experienced centres, the effectiveness of 
this treatment is estimated at 93–95% [8]. The success 
of the procedure depends mainly on the variability of an 
individual’s venous system anatomy and possible phrenic 
nerve stimulation (PNS). Perioperative complications are 
rare, but must be taken into consideration. Such possible 
complications include:
 — coronary sinus dissection (2.1–3.3%);
 — left-chamber electrode dislocation (4–13.6%);
 — PNS (1.5–12%);
 — infections (1.3–3.4%).
Methods of preventing  
phrenic nerve stimulation
In patients after CRT implantation, the main problem limiting 
permanent two-chamber stimulation is the high threshold 
for left-ventricular electrode stimulation and phrenic nerve 
stimulation. In this paper, we are focusing on different 
methods of phrenic nerve stimulation avoidance. Sensing, 
pacing threshold (i.e. the lowest voltage causing effective 
left ventricular contraction), and PNS threshold are asses-
sed in patients after left ventricular electrode placement 
[9]. After successful CRT implantation, it has been noted 
that approximately one third of patients have PNS [10].
The first way to avoid this is to reposition the left 
ventricular electrode, which extends the duration of the 
procedure, and is possible only with appropriate epicardial 
vein anatomy.
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The second alternative method for bipolar electrodes 
is electrode polarisation reprogramming — stimulation 
vectors (Figure 1). Thanks to this, we have the option to 
programme different ventricular muscle stimulation vectors 
in these electrodes. We are always looking for a suitable 
vector that causes effective resynchronisation stimulation 
in the absence of PNS. The basic stimulation vector is the 
one in which an electrical impulse is delivered from the tip 
to the left ventricular electrode ring (LVtip–LVring). Thanks 
to this, we get bipolar stimulation at the very tip of the 
electrode which minimises the risk of PNS. The second 
vector is stimulation between the left ventricular electrode 
tip (LVtip) and the right ventricular electrode ring (RVring). 
The third and last available stimulation vector to check is 
the stimulation between the left-cell electrode ring (LVring) 
and the right-cell electrode coil (RVcoil). Changing the po-
larity of the left ventricular electrode to avoid PNS was the 
purpose of the ORPHEE (Bipolar Leads for Prevention of 
Phrenic Nerve Stimulation) study [11]. This multicentre ob-
servational study was conducted in France in 2012–2015. 
It included 90 patients who met the criteria for CRT-D im-
plantation [91% — primary prevention of SCD; 9% secondary 
prevention of SCD (83.3% de novo implantation, 16.7% 
— systemic extension)]. The mean age of patients was: 
70.2 ± 8.9 years, mean EF 28.0% ± 5.5%, mean follow-up 
226.3 ± 98.7 days. After placing the left ventricular elec-
trode in the epicardial vein (stable stimulation threshold 
< 2.5 V), the occurrence of phrenic nerve stimulation was 
assessed. No PNS stimulation was defined as no PNS at 
a threshold > 7 V, or no PNS after changing the polarity 
of the LV electrode. The aim of the study was to show that 
changing the polarisation of the LV electrode (LVtip–LVring, 
LVtip–RVring, LVring–RVcoil) prevents the occurrence of 
PNS in at least 90% of patients. Of all patients included 
in the study, 10 patients were withdrawn from the study: 
nine due to the high threshold of LV electrode stimulation 
> 2.5 V, and one due to the lack of a PNS test. Eventually, 
80 patients were enrolled in the study, of whom 12 (15%) 
had phrenic nerve stimulation. In only 10 out of 12 patients 
was a change in electrode polarity associated with a lack 
of PNS [LVring–RVcoil: eight patients (8/10, 80%); LVtip– 
–LVring: one patient (1/10, 10%); LVtip–RVring one patient 
(1/10, 10%)]. In the entire study population (n = 90), the 
finally programmed LV electrode stimulation vectors were 
as follows: LV vectors were LVtip–LVring (37.1%), LVtip– 
–RVring (32.6%), and LVring–RVcoil (30.3%). The authors 
of the study emphasised that after implantation of CRT-D, 
PNS occurred in 15% of patients. In nearly all of the patients 
(78/80, 97.5%) PNS could be avoided by changing the left 
ventricular electrode stimulation vector alone. In patients 
whose heart vein anatomy prevents four-pole electrode 
implantation, bipolar electrode implantation is a suitable 
and reliable alternative.
The third and final way to avoid PNS during CRT im-
plantation is to use a quadripolar electrode during the 
procedure. This solution was evaluated in a multicentre 
study with the acronym EffaceQ (Effectiveness and Re-
liability of Selected Site Pacing for Avoidance of Phrenic 
Nerve Stimulation in CRT Patients with Quadripolar LV 
Leads) [12], in which 344 patients were enrolled. The aim 
of the study was to demonstrate that in at least 90% of 
patients with an implanted quadripolar electrode, chan-
ges in electrical pulse polarity in the absence of phrenic 
pacing (LV ≤ 2.5 V/0.5 ms) are effective in lowering the 
left ventricular pacing threshold. The results showed that 
PNS stimulation was present in 65.0% of patients during 
CRT implantation. Reprogramming of the left ventricle 
electrode polarity was performed in 49.8% of patients. 
PNS was assessed to decrease from distal to proximal ring 
stimulation, while LV stimulation thresholds increased from 
distal to proximal ring. The conclusions emphasised that 
the change in polarity of the quadripolar left ventricular 
Figure 1A, B. Left ventricular bipolar electrode — available stimulation vectors (1. LVtip–LVring; 2. LVring–RVcoil; 3. LVtip–RVcoil); LV — left 
ventricle; RV — right ventricle)
A B
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electrode is an alternative to non-invasive repositioning of 
LV stimulation to avoid PNS.
Currently, each of the CRT manufacturers offers such 
electrodes. They differ in diameter, shape, length, ar-
rangement of stimulation rings, and the place of steroid 
release in order to prevent the phenomenon of increasing 
stimulation’s threshold. These electrodes increase the 
chance of successful stimulation of the left ventricular 
muscle even in a case of slight dislocation. This requires 
changing the settings of the stimulation vector, which, de-
pending on the manufacturer, can be from 10 (Figure 2B) 
to as much as 17 [13]. Then, no further treatment to re-
position the electrode is required. This extends the time 
of the procedure, associated with the time to look for the 
optimal vector for effective left ventricular muscle stimula-
tion and the lack of PNS. Many registries have shown lower 
mortality in patients with CRT using a quadripolar electrode 
compared to a bipolar electrode [9]. The use of quadripolar 
electrodes significantly reduces the percentage of patients 
in whom left ventricular stimulation causes PNS. In ad-
dition, a large area of the stimulation ring, ranging from 
16 to 64 mm depending on the manufacturer, causes no 
difference in response to electrotherapy between patients 
with ischaemic and non-ischaemic aetiology of chronic 
HF. This suggests improved response to CRT therapy in 
patients after myocardial infarction [14]. An additional 
advantage of quadripolar electrodes is the possibility of 
using multipoint stimulation with one electrode. This is 
particularly important in patients with areas of myocardial 
necrosis that significantly impair the propagation of elec-
trical impulses, thus inhibiting synchronous contraction 
of the left ventricle. In this case, the use of multipoint 
stimulation with a quadripolar electrode allows stimulation 
of the myocardial areas with a sequential/simultaneous 
pulse that would not be possible with the use of one sti-
mulation pulse. Multipoint stimulation covering a larger 
area of the left ventricle causes earlier stimulation of the 
places with the latest electrical activation, which results 
in improved synchronisation of contraction and increased 
cardiac output.
In the electrocardiogram, this is manifested by nar-
rowing of the stimulated QRS complexes. Due to such 
advanced techniques, it is believed that multipoint stimu-
lation in certain groups of patients may cause inverted left 
ventricular remodelling. In addition, multipoint stimulation 
gives a chance to improve the haemodynamic response, 
and hence the prognosis, in patients who did not achieve 
the expected effects of current dual-chamber stimula-
tion. However, some studies do not explicitly confirm the 
advantage of this stimulation method over current CRT 
stimulation [15].
Summary
Resynchronisation therapy is a well-recognised method 
of chronic HF treatment, especially in patients who show 
no clinical improvement despite optimal pharmacological 
treatment. 
The biggest challenge for the operator is implantation 
of the left ventricular electrode through the heart system. 
The success of this procedure is hindered by the variability 
of the anatomy of the heart’s venous system and the incre-
asingly more common PNS. Modern technology allows the 
use of left-ventricular electrodes: bipolar and quadripolar, 
together with the variable polarity of the stimulation vector 
to avoid PNS. This has a positive effect on improving the 
effectiveness of electrotherapy, while minimising the risk 
of complications and the need for subsequent treatments.
Figure 2A, B. Quadripolar left ventricular electrode — available stimulation vectors (1. D1–M2; 2. D1–P4; 3. D1–RVcoil; 4. M2–P4; 
5. M2–RVcoil; 6. M3–M2; 7. M3–P4; 8. M3–RVcoil; 9. P4–M2; 10. P4–RVcoil); D — distal; M — mid; P — proximal; RV — right ventricle
A B
Ten stimulation vectors
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